Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3

Hybrid Hybridomics. 2004 Feb;23(1):23-7. doi: 10.1089/153685904322771999.

Abstract

PRL-3 is a newly identified nonclassical protein tyrosine phosphatase associated with colorectal cancer metastasis. To prepare specific monoclonal antibody (MAb) against PRL-3, cDNAs of PRL-1, -2, and -3 were cloned by RT-PCR and inserted into prokaryotic expression vector pGEX-4T1, respectively. The fusion proteins were expressed in Escherichia coli. Monoclonal antibody against PRL-3 was obtained with hybridoma technique and specific ELISA screening. Western blotting and immunohistochemistry assays showed that MAb 3B6 had specific binding ability with PRL-3 protein in eukaryotic cells. This MAb will be a helpful tool for the detection of PRL-3 protein in the tissues and serum of colorectal cancer and other cancer patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis
  • Antibodies, Monoclonal / immunology*
  • Base Sequence
  • Blotting, Western
  • Cloning, Molecular
  • DNA Primers
  • DNA, Complementary
  • Enzyme-Linked Immunosorbent Assay
  • HT29 Cells
  • Humans
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / immunology*
  • Immunohistochemistry
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Proteins
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / immunology*
  • Recombination, Genetic

Substances

  • Antibodies, Monoclonal
  • DNA Primers
  • DNA, Complementary
  • Immediate-Early Proteins
  • Neoplasm Proteins
  • PTP4A3 protein, human
  • Protein Tyrosine Phosphatases